The second-gen glasses aren’t groundbreaking, but they’re improved. And for anyone who’s not willing to spend $800 on the ...
Zacks Investment Research on MSN
FDA Approves Label Extension of REGN's Cholesterol Drug Evkeeza
Regeneron Pharmaceuticals, Inc. REGN announced that the FDA has approved a label extension of its cholesterol drug Evkeeza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback